Pharmacognosy intro
Althaea officinalis L. (Malvaceae), commonly known as marshmallow or marsh mallow, is a tall perennial herb native to Europe, Western Asia, and North Africa, naturalized in eastern North America. It grows in damp, marshy habitats. The species name derives from the Greek altho (to heal), and the root is the primary medicinal material due to its high mucilage content. Leaves and flowers are also used. The root is harvested in autumn from plants at least two years old. The dominant bioactive constituents are mucilage polysaccharides, comprising 25 to 35% of the dried root weight. These are heterogeneous mixtures of galacturonic acid, glucuronic acid, galactose, arabinose, and rhamnose residues. Galacturonan pectins contribute additional gel-forming capacity. The root also contains approximately 37% starch. The flavonoid hypolaetin-8-glucoside is specific to A. officinalis and contributes direct anti-inflammatory activity. Additional flavonoids include kaempferol and quercetin. Phenolic acids (caffeic, p-coumaric, ferulic, vanillic acid), scopoletin, and small quantities of tannins are present. Notably, the amino acid asparagine was originally isolated from this species and takes its name from it. Marshmallow root's primary mechanism is physical rather than receptor-mediated. The mucilage polysaccharides form a viscous, bioadhesive film over epithelial surfaces including oral mucosa, esophagus, stomach lining, intestinal epithelium, and respiratory tract. This layer physically shields irritated or inflamed tissue from gastric acid, digestive enzymes, inhaled irritants, and mechanical friction during swallowing and peristalsis. The antitussive effect follows the same physical principle: mucilage coating the pharyngeal and laryngeal mucosa reduces cough receptor trigger sensitivity, producing cough suppression through mechanical means distinct from opioid-mediated suppression. The German Commission E approved marshmallow for dry, irritating cough on this basis. The flavonoid fraction, particularly hypolaetin-8-glucoside, provides direct anti-inflammatory activity through inhibition of histamine release and reduced leukotriene synthesis. Naseri et al. (2020, Phytotherapy Research) conducted a pilot RCT comparing marshmallow root topical preparation against hydrocortisone 1% cream for mild-to-moderate atopic dermatitis. The marshmallow preparation outperformed hydrocortisone, producing significant reductions in the SCORAD (Scoring Atopic Dermatitis) index, erythema, and pruritus. This is a notable finding: a plant mucilage exceeding a corticosteroid in a controlled comparison. Additional clinical applications supported by evidence or Commission E approval include gastritis and dyspepsia (mucosal coating), sore throat and pharyngitis, and chemotherapy-induced oral mucositis. Mucilage is not systemically absorbed, which means marshmallow's effects are local. This also creates a practical pharmacokinetic consideration: mucilage may physically delay absorption of co-administered oral drugs, requiring separation by at least one hour.